Gantzert Investment Company’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$3.87M Sell
15,215
-1,335
-8% -$331K 3.49% 8
2020
Q2
$3.9M Sell
16,550
-950
-5% -$217K 3.83% 8
2020
Q1
$3.55M Sell
17,500
-300
-2% -$65.5K 3.81% 7
2019
Q4
$4.29M Sell
17,800
-1,060
-6% -$234K 3.92% 7
2019
Q3
$3.65M Sell
18,860
-2,335
-11% -$448K 3.58% 7
2019
Q2
$3.91M Hold
21,195
3.85% 5
2019
Q1
$4.03M Sell
21,195
-280
-1% -$53.5K 4.08% 4
2018
Q4
$4.18M Buy
+21,475
New +$4.19M 4.66% 1

Other funds holding AMGN

Gantzert Investment Company's AMGN Position: Q3 2020 in Review

Gantzert Investment Company reduced its Amgen (AMGN) stake by 8.1% in Q3 2020, selling an estimated $331K and leaving 15,215 shares worth $3.87M. The position accounts for 3.49% of the portfolio, ranked #8.

Gantzert Investment Company first reported a position in AMGN in Q4 2018 and has held it in 8 quarters since. The position peaked at $4.29M in Q4 2019. 2,128 funds tracked by Wall St. Rank hold AMGN as of Q3 2020.

  • Gantzert Investment Company held 15,215 shares of Amgen worth $3.87M as of Q3 2020.
  • Gantzert Investment Company sold 1,335 Amgen shares in Q3 2020, an estimated $331K.
  • Amgen made up 3.49% of Gantzert Investment Company's portfolio in Q3 2020, its #8 holding.
  • Gantzert Investment Company first reported a position in Amgen in Q4 2018 and has held it in 8 quarters since.
  • Gantzert Investment Company's Amgen position peaked at $4.29M in Q4 2019.
  • 2,128 funds tracked by Wall St. Rank held Amgen as of Q3 2020.

Based on Gantzert Investment Company's 13F filing for Q3 2020, filed 7 Oct 2020.